GTx Inc. to merge with Oncternal Therapeutics, end Memphis operations

By  and , Daily Memphian Updated: March 07, 2019 11:55 PM CT | Published: March 07, 2019 9:51 AM CT

Memphis-based biopharmaceutical company GTx Inc. and a San Diego-based biotech firm are planning a reverse merger that will end GTx’s Memphis operations.

Bluff City Biz

Sign up to get the latest news and analysis from our Business team.

Manage Your Email Subscriptions

Topics

GTx Inc. Oncternal Therapeutics
Natalie Martin

Natalie Martin

Natalie Martin is a Memphis native and 2018 graduate of the University of Memphis. She is a digital desk designer for The Daily Memphian.

Kate Crawford

Kate Crawford

Associate editor Kate Crawford is a native Memphian and third-generation University of Memphis alumna.


Comments

Reading comments and joining the conversation are some of the many benefits of subscribing. Join the conversation by clicking the View Comments button below. Not a subscriber? Click here. 

Our commenting policy can be viewed here

Bluff City Biz

Sign up to get the latest news and analysis from our Business team.

Manage Your Email Subscriptions